Corporate Europe Observatory

Exposing the power of corporate lobbying in the EU

-- placeholder --

The corporate lobby tour

The official EU assessment of glyphosate was based on unpublished studies owned by industry. Seven months later, the pesticide industry still fights disclosure and, so far, successfully. We obtained a copy of their arguments.

The European Commission proposal on scientific criteria defining endocrine disruptors (EDCs) is the latest dangerous outgrowth of a highly toxic debate. The chemical lobby, supported by certain Commission factions (notably DG SANTE and the Secretary-General) and some member states (UK and Germany), has put significant obstacles in the way of effective public health and environment regulation.

In recent times we have seen various examples of green activists “coming out” as GMO-proponents, arguing that GMOs are safe and have multiple benefits: reduced pesticide use, higher income for farmers, contributing to food security, reduced greenhouse gas emissions... As an essential part of their discourse, organisations that continue to reject GMO technology are depicted as old-fashioned and as acting in contradiction to their own aims.

Mark Lynas is a well known example of this in the UK, with an (in)famous public apology for his past role in the anti-GM movement that drew a lot of media attention. Lynas' move has been copied by others, like blogger Stijn Bruers in Belgium. This framing of the GMO debate has proven quite attractive to the media, even though it is not always clear why specifically these people are seen to have the credentials to merit this attention.

There are many fundamental flaws in the argumentation they are putting forward. Claire Robinson of GMWatch, at the request of Corporate Europe Observatory, has written a rebuttal of many of the claims made by these newly converted GMO proponents. For practical reasons, this rebuttal follows the argumentation and claims made in an article by Bruers on his blog about GMOs .

This May is dense on the EU chemicals regulation front. Crunch time for two major files: the European Commission needs to publish the identification criteria for endocrine disrupting chemicals, and together with EU States must decide how, or not, renew the market approval of glyphosate, an herbicide produced and defended by Monsanto. Last week, the Professor Alan Boobis happened to be involved in both.